04.10.24 -- Evolution Of Drug Packaging

Review the FDA's revised 2016 diversity guidance, which establishes clear expectations and standardizes recommendations for gathering and reporting race and ethnicity data.

Learn how no-code solutions enable faster, less costly system implementation and validation, helping to reduce costs and timelines during the drug and medical device development and approval process.

What are some steps you can take to transition to a more robust and quality-driven data cleaning and central monitoring strategy? Explore three considerations to keep in mind as you start the journey.

Learn in detail about the Military Outreach and Veterans Engagement (MOVE) program, launched by the North Carolina Biotechnology Center in 2019, as well as the growing opportunities in North Carolina.

Did you know that the average cost for a delayed trial is between $600,000 and $8 million per day? Discover how electronic consent management technology is helping sponsors, CROs, and sites.

Review key factors for building a reliable CLD strategy, and learn how the right CDMO can help you achieve the high quality, high yield, and speed needed to successfully bring a biologic to market.

A commercial packaging solution can be the first and enduring impression that a sponsor company makes on a patient, and its suitability can impact a biologic’s commercial success.